Michael Bitzer
About
Michael Bitzer is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Michael Bitzer has authored 198 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 48 papers in Oncology and 46 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Bitzer's work include Virus-based gene therapy research (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Michael Bitzer is often cited by papers focused on Virus-based gene therapy research (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (26 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Michael Bitzer collaborates with scholars based in Germany, United States and Switzerland. Michael Bitzer's co-authors include Ulrich M. Lauer, Sascha Venturelli, Sorin Armeanu, Michael Gregor, Wilfried Budach, M. Stahl, Jorge Riera‐Knorrenschild, Martin K. Walz, Martin Stuschke and H. Wilke and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Communications.
In The Last Decade
Michael Bitzer
183 papers receiving 5.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Michael Bitzer Germany | 43 | 1.5k | 1.4k | 1.3k | 1.3k | 991 | 198 | 5.6k | ||
| Pieter Demetter Belgium | 43 | 1.8k 1.2× | 691 0.5× | 1.2k 0.9× | 2.5k 2.0× | 993 1.0× | 199 | 6.4k | ||
| Jochen K. Lennerz United States | 48 | 3.1k 2.0× | 2.2k 1.5× | 1.5k 1.1× | 2.7k 2.1× | 967 1.0× | 222 | 10.0k | ||
| Nisar P. Malek Germany | 44 | 2.5k 1.6× | 492 0.3× | 916 0.7× | 1.6k 1.2× | 862 0.9× | 188 | 5.3k | ||
| Daniel Neureiter Austria | 42 | 2.1k 1.4× | 863 0.6× | 1.2k 0.9× | 1.5k 1.2× | 680 0.7× | 241 | 5.9k | ||
| Renzo Boldorini Italy | 37 | 911 0.6× | 939 0.7× | 793 0.6× | 1.8k 1.4× | 770 0.8× | 242 | 5.3k | ||
| José Luís Mate Spain | 34 | 921 0.6× | 1.6k 1.2× | 713 0.5× | 1.5k 1.2× | 1.1k 1.1× | 144 | 4.8k | ||
| Dominik T. Schneider Germany | 47 | 2.3k 1.5× | 1.4k 1.0× | 2.7k 2.0× | 766 0.6× | 841 0.8× | 230 | 6.7k | ||
| Bronno van der Holt Netherlands | 51 | 2.1k 1.4× | 966 0.7× | 616 0.5× | 3.0k 2.4× | 882 0.9× | 224 | 7.8k | ||
| Athanasios G. Tzioufas Greece | 58 | 1.5k 1.0× | 654 0.5× | 2.6k 1.9× | 987 0.8× | 853 0.9× | 335 | 11.7k | ||
| Mengtao Li China | 37 | 858 0.6× | 1.2k 0.8× | 586 0.4× | 793 0.6× | 923 0.9× | 375 | 5.5k |
Countries citing papers authored by Michael Bitzer
Since
Specialization
Citations
This map shows the geographic impact of Michael Bitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bitzer more than expected).
Fields of papers citing papers by Michael Bitzer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Michael Bitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bitzer. The network helps show where Michael Bitzer may publish in the future.
Co-authorship network of co-authors of Michael Bitzer
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bitzer. A scholar is included among the top collaborators of Michael Bitzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bitzer. Michael Bitzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Rieke, Damian, Michael Bitzer, Annalen Bleckmann, et al.. (2025). Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology. European Journal of Cancer. 220. 115331–115331.
2.
Bissinger, Rosi, Anna Liu, Claire Cannet, et al.. (2023). Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients. Frontiers in Immunology. 14. 1144224–1144224.
3.
Lordick, Florian, Peter Thuss‐Patience, Michael Bitzer, et al.. (2023). Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer. Journal of Cancer Research and Clinical Oncology. 149(9). 5937–5950.
4.
Bauer, Jens, Jonas S. Heitmann, Yacine Maringer, et al.. (2023). FusionVAC22_01: A phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion. Zeitschrift für Gastroenterologie. 61(8). e374–e374.
5.
Bitzer, Michael, et al.. (2023). Substitution Effect, Turnout Effect, or Both? Changes in Distance to the Early Voting Site and Voter Turnout. Election Law Journal Rules Politics and Policy. 22(3). 278–285.
6.
Zlamal, Jan, Karina Althaus, Helene Häberle, et al.. (2022). Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19. Blood Advances. 6(1). 248–258.
7.
Grosse, Ulrich, Konstantin Nikolaou, Roland Syha, et al.. (2021). Intraprocedural cone-beam CT with parenchymal blood volume assessment for transarterial chemoembolization guidance: Impact on the effectiveness of the individual TACE sessions compared to DSA guidance alone. European Journal of Radiology. 140. 109768–109768.
8.
Spahn, Stephan, Daniel Roessler, Gisela Gabernet, et al.. (2020). Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma. Cancers. 12(12). 3830–3830.
9.
Althaus, Karina, Irene Marini, Jan Zlamal, et al.. (2020). Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood. 137(8). 1061–1071.
10.
Bösmüller, Hans, Michael Bitzer, Helene Häberle, et al.. (2020). The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(3). 349–357.
11.
Reinmuth, Niels, Michael Bitzer, Barbara Deschler-Baier, et al.. (2019). Nebenwirkungsmanagement in der Immunonkologie : Praktische Aspekte im Management immunvermittelter Nebenwirkungen unter immunonkologischer Therapie. DMW - Deutsche Medizinische Wochenschrift. 144(5). 346–353.
12.
Lauer, Ulrich M., Susanne Berchtold, Jörg Glatzle, et al.. (2018). Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis. Clinical Cancer Research. 24(18). 4388–4398.
13.
Venturelli, Sascha, Tobias Sinnberg, Alexander Berger, et al.. (2014). Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells. Frontiers in Oncology. 4. 227–227.
14.
Yurttas, Can, Susanne Berchtold, Nisar P. Malek, Michael Bitzer, & Ulrich M. Lauer. (2014). “PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. 776275620–776275620.
15.
Yurttas, Can, Susanne Berchtold, Nisar P. Malek, Michael Bitzer, & Ulrich M. Lauer. (2014). Pulsed Versus Continuous Application of the Prodrug 5-Fluorocytosine to Enhance the Oncolytic Effectiveness of a Measles Vaccine Virus Armed with a Suicide Gene. PubMed. 25(2). 85–96.
16.
Venturelli, Sascha, Alexander Berger, Timo Weiland, et al.. (2013). Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells. Molecular Cancer Therapeutics. 12(10). 2226–2236.
17.
Weiland, Timo, Alexander Berger, Frank Eßmann, et al.. (2011). Kinetic Tracking of Therapy-Induced Senescence Using the Real-Time Cell Analyzer Single Plate System. Assay and Drug Development Technologies. 10(3). 289–295.
18.
Mühlebach, Michael D., Thomas Schaser, Martina Zimmermann, et al.. (2010). Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus. Cancer Research. 70(19). 7620–7629.
19.
Bitzer, Michael, et al.. (2007). Management Decision Support By PLM Solutions. Guidelines for a Decision Support Method Adapted to NPD Processes.
20.
Warmann, Steven W., Sorin Armeanu, Peter Ruck, et al.. (2006). Optimizing vector application for gene transfer into human hepatoblastoma cells. Pediatric Surgery International. 22(9). 733–742.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Pieter Demetter Breakdown of academic impact, for papers by Jochen K. Lennerz Breakdown of academic impact, for papers by Nisar P. Malek Breakdown of academic impact, for papers by Daniel Neureiter Breakdown of academic impact, for papers by Renzo Boldorini Breakdown of academic impact, for papers by José Luís Mate Breakdown of academic impact, for papers by Dominik T. Schneider Breakdown of academic impact, for papers by Bronno van der Holt Breakdown of academic impact, for papers by Athanasios G. Tzioufas Breakdown of academic impact, for papers by Mengtao Li